glp-1 weight loss drugs Medications: Everything You Need to Know Patients' Use GLP-1 Drugs for

These therapies, initially designed for type 2 diabetes, have demonstrated significant weight loss benefits, leading to their expanded use in obesity management

[DOI] [PubMed] [Google Scholar] 96.Yang X, et al

But theyve also long carried a black box warning about the possible risk of thyroid cancer, specifically medullary thyroid cancer (MTC)

All GLP-1 receptor agonists delay gastric emptying, which may affect the absorption of other oral medications (713)

Age, weight, and sex impact Older patients had a lower IGE risk with dulaglutide and semaglutide

In the Carmina study, 33% of participants experienced morning nausea, and about 7% dealt with occasional vomiting